Selpercatinib Shows Promise as a Treatment for Non-Small Cell Lung Cancer
by A recent multicenter study, known as the phase III LIBRETTO-431 trial, has assessed the efficacy and safety of selpercatinib as a treatment for non-small cell …
Unleashing Industry Insights, Connecting the Future